1. A Universal Fluorescent Immunochromatography Assay Based on Quantum Dot Nanoparticles for the Rapid Detection of Specific Antibodies against SARS-CoV-2 Nucleocapsid Protein
- Author
-
Zehui Li, Aiping Wang, Jingming Zhou, Yumei Chen, Hongliang Liu, Yankai Liu, Ying Zhang, Peiyang Ding, Xifang Zhu, Chao Liang, Yanhua Qi, Enping Liu, and Gaiping Zhang
- Subjects
SARS-CoV-2 ,viruses ,Organic Chemistry ,COVID-19 ,General Medicine ,Nucleocapsid Proteins ,Antibodies, Viral ,Sensitivity and Specificity ,Catalysis ,Chromatography, Affinity ,Computer Science Applications ,Inorganic Chemistry ,Quantum Dots ,Animals ,Physical and Theoretical Chemistry ,fluorescent immunochromatography assay ,nucleocapsid protein ,quantum dots ,point-of-care detection ,Molecular Biology ,Spectroscopy - Abstract
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the pathogenic agent leading to COVID-19. Due to high speed of transmission and mutation rates, universal diagnosis and appropriate prevention are still urgently needed. The nucleocapsid protein of SARS-CoV-2 is considered more conserved than spike proteins and is abundant during the virus’ life cycle, making it suitable for diagnostic applications. Here, we designed and developed a fluorescent immunochromatography assay (FICA) for the rapid detection of SARS-CoV-2-specific antibodies using ZnCdSe/ZnS QDs-conjugated nucleocapsid (N) proteins as probes. The nucleocapsid protein was expressed in E.coli and purified via Ni-NTA affinity chromatography with considerable concentration (0.762 mg/mL) and a purity of more than 90%, which could bind to specific antibodies and the complex could be captured by Staphylococcal protein A (SPA) with fluorescence displayed. After the optimization of coupling and detecting conditions, the limit of detection was determined to be 1:1.024 × 105 with an IgG concentration of 48.84 ng/mL with good specificity shown to antibodies against other zoonotic coronaviruses and respiratory infection-related viruses (n = 5). The universal fluorescent immunochromatography assay simplified operation processes in one step, which could be used for the point of care detection of SARS-CoV-2-specific antibodies. Moreover, it was also considered as an efficient tool for the serological screening of potential susceptible animals and for monitoring the expansion of virus host ranges.
- Published
- 2022